Project #39: Appropriate Preoperative Screening in Low-Risk Surgeries

Authors

Pat Patton, Henry Ford HealthFollow
Rupen Shah, Henry Ford HealthFollow
Marianne Franco, Henry Ford HealthFollow
Cletus Stanton, Henry Ford HealthFollow
Lynda Lopis, Henry Ford HealthFollow
Kelsey Sale, Henry Ford HealthFollow
Sicknee Daher, Henry Ford HealthFollow
Jacqueline J. Machnacki, Henry Ford HealthFollow
Kelly Bourn, Henry Ford HealthFollow
Jessica Wren, Henry Ford HealthFollow

Files

Description

Background: Research shows that routine preoperative testing in elective low risk surgeries: Costs the U.S. an estimated $85.2 million annually; May add to patient’s personal financial burden; Does not improve patient outcomes; Clinically insignificant results can lead to delays in needed care prolonging pain and suffering and additional decompensation.

Clinically insignificant testing can also lead to a cascade of additional unnecessary testing.

PROBLEM STATEMENT: Unnecessary testing leads to increased cost and potential delays in care with no ROI (Return on Investment).

GOAL: Decrease unnecessary preoperative testing rates in patients undergoing any of 3 elective low risk surgeries (lap cholecystectomy, minor hernia repair, and breast lumpectomy) by 20% by the end of 2023.

Publication Date

3-12-2024

Publisher

Henry Ford Health

City

Detroit, Michigan

Keywords

Quality Expo, posters, poster competition

Recommended Citation

Patton, Pat; Shah, Rupen; Franco, Marianne; Stanton, Cletus; Lopis, Lynda; Sale, Kelsey; Daher, Sicknee; Machnacki, Jacqueline J.; Bourn, Kelly; and Wren, Jessica, "Project #39: Appropriate Preoperative Screening in Low-Risk Surgeries" (2024). Quality Expo 2024. 42.
https://scholarlycommons.henryford.com/qualityexpo2024/42